Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

NeoGenomics Q4 2023 Adj EPS $0.03 Beats $(0.02) Estimate, Sales $155.55M Beat $152.54M Estimate

Author: Benzinga Newsdesk | February 20, 2024 05:09pm
NeoGenomics (NASDAQ:NEO) reported quarterly earnings of $0.03 per share which beat the analyst consensus estimate of $(0.02) by 250 percent. The company reported quarterly sales of $155.55 million which beat the analyst consensus estimate of $152.54 million by 1.98 percent. This is a 12.15 percent increase over sales of $138.71 million the same period last year.

Posted In: NEO


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist